Research from "Vasile Goldis" Western University of Arad Provide New Insights into Personalized Medicine (Serum YKL-40 Levels, Leukocyte Profiles, and Acute Exacerbations of Advanced COPD).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Subject Terms:
    • Subject Terms:
    • Abstract:
      According to the news editors, the research concluded: "These results reveal multidimensional, YKL-40-associated changes in leukocyte profile of patients with advanced COPD during acute exacerbations, with potential implications for personalized treatment." Keywords: Basophils; Blood Cells; Cell Research; Chronic Obstructive Pulmonary Disease; Drugs and Therapies; Eosinophils; Granulocytes; Health and Medicine; Hemic and Immune Systems; Immunology; Leukocytes; Lung Diseases and Conditions; Lymphocytes; Mononuclear Leukocytes; Neutrophils; Personalized Medicine; Personalized Therapy; Phagocytes EN Basophils Blood Cells Cell Research Chronic Obstructive Pulmonary Disease Drugs and Therapies Eosinophils Granulocytes Health and Medicine Hemic and Immune Systems Immunology Leukocytes Lung Diseases and Conditions Lymphocytes Mononuclear Leukocytes Neutrophils Personalized Medicine Personalized Therapy Phagocytes 1907 1907 1 10/09/23 20231013 NES 231013 2023 OCT 13 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Current study results on personalized medicine have been published. [Extracted from the article]
    • Abstract:
      Copyright of Respiratory Therapeutics Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)